Blog
RSS FeedPosted by Michael Wonder on 21 Apr 2020
Pharmacists welcome medicine review update
21 April 2020 - Elderly people at risk of medicine-related harm will now have their treatments more regularly reviewed by ...
Posted by Michael Wonder on 08 Jan 2020
PBAC – 2019 in review
8 January 2020 - The PBAC considered 188 submissions in 2019. ...
Posted by Michael Wonder on 03 Dec 2019
The use of risk-sharing contracts in health care: theoretical and empirical assessments
3 December 2019 - The aim of this review is to provide a summary of the literature on risk-sharing agreements, including ...
Posted by Michael Wonder on 01 Dec 2019
The ‘Top 10’ challenges for health technology assessment: INAHTA viewpoint
28 November 2019 - The International Network of Agencies for Health Technology Assessment (INAHTA) spans the globe as a network of ...
Posted by Michael Wonder on 18 Nov 2019
Biostatistics: a fundamental discipline at the core of modern health data science
28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...
Posted by Michael Wonder on 09 Oct 2019
High health care costs suggest review is needed: report
8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...
Posted by Michael Wonder on 03 Sep 2019
Bad diagnosis: health care system muddled, lacking leadership major report finds
3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...
Posted by Michael Wonder on 28 Aug 2019
Patient Voice Aotearoa calls for PHARMAC reform
28 August 2019 - Patient Voice Aotearoa has launched a petition calling for the Minister of Health to initiate an ...
Posted by Michael Wonder on 22 Jul 2019
NICE numbers at 20
19 July 2019 - Leela Barham takes a look at NICE’s stats on technology appraisals to see how the agency ...
Posted by Michael Wonder on 22 Jul 2019
NICE announces details of health technology evaluation methods review
22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...
Posted by Michael Wonder on 22 Jul 2019
Australia's National Medicines Policy is outdated and in need of review
22 July 2019 - How will issues such as disruptive innovation, precision medicine and climate change affect Australia's medicines policy ...
Posted by Michael Wonder on 13 Jul 2019
Early benefit assessment reveals weaknesses in the development of new drugs
11 July 2019 - Analysis of 216 AMNOG assessments in the BMJ / Proposals for more targeted drug development ...
Posted by Michael Wonder on 08 Jul 2019
Report calls for European funding reform for gene therapies
8 July 2019 - New payment models, dedicated investment, and better health technology assessment are among a raft of changes ...
Posted by Michael Wonder on 08 Jul 2019
Pharma giant wants vaccination reform
9 July 2019 - Pharmaceutical giant GSK is calling for Australia to update its review of subsidised immunisation programs and ...
Posted by Michael Wonder on 17 Jun 2019
Population adjustment methods for indirect comparisons: A review of NICE Technology Appraisals
13 June 2019 - Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, ...